Page last updated: 2024-11-04

spiperone and Airflow Obstruction, Chronic

spiperone has been researched along with Airflow Obstruction, Chronic in 2 studies

Spiperone: A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.
spiperone : An azaspiro compound that is 1,3,8-triazaspiro[4.5]decane which is substituted at positions 1, 4, and 8 by phenyl, oxo, and 4-(p-fluorophenyl)-4-oxobutyl groups, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Zhu, D1
Ma, N1
Chen, L1
Huang, J1
Zhong, X1
Birrell, MA1
Crispino, N1
Hele, DJ1
Patel, HJ1
Yacoub, MH1
Barnes, PJ1
Belvisi, MG1

Other Studies

2 other studies available for spiperone and Airflow Obstruction, Chronic

ArticleYear
Verification of the role of spiperone in the treatment of COPD through bioinformatics analysis.
    International immunopharmacology, 2021, Volume: 101, Issue:Pt A

    Topics: Adult; Blotting, Western; Female; Humans; Hydrolases; Male; Metabolic Networks and Pathways; Middle

2021
Effect of dopamine receptor agonists on sensory nerve activity: possible therapeutic targets for the treatment of asthma and COPD.
    British journal of pharmacology, 2002, Volume: 136, Issue:4

    Topics: Animals; Asthma; Capillary Permeability; Capsaicin; Dopamine; Dopamine Agonists; Dopamine Antagonist

2002